Skip to main content
Superior histological outcomes with vedolizumab vs adalimumab in ulcerative colitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Superior histological outcomes with vedolizumab vs adalimumab in ulcerative colitis
User login
Username
Password
Reset your password
Concept
Lead
score
Inflammatory Bowel Disease
1
0.97
Biologic Therapy
0
0.81
Biosimilars
0
0.81
Remission
0
0.49
Biomarker
0
0.16
Colitis
0
0.16
Grant
0
0.16
Pain
0
0.16
Pain Management
0
0.16
Specialty
Lead
score
Gastroenterology
1
1
Nursing
0
0.91
Pharmacist
0
0.91
Family Medicine/Primary Care
0
0.28
Internal Medicine
0
0.28
Anesthesiology
0
0.16